Evidence map›Paper›PMID 42099631›Full record

ReviewFrontiers in immunology2026

Skeletal muscle as a dynamic immunological niche for vaccination.

Moataz Noureddine, Michael Schotsaert

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Moataz NoureddineDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Michael SchotsaertDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intramuscular vaccination has long been a cornerstone of preventive medicine and has substantially reduced global mortality from infectious disease. As vaccine development has expanded to address increasingly complex targets, including chronic infections and cancer, it has become clear that vaccine efficacy depends not only on antigen design but also on the inflammatory and cellular cues present at the site of delivery. Despite this, the skeletal muscle-the most common site of vaccine administration-has received comparatively little attention as an immunological environment. Skeletal muscle is a highly dynamic, regenerative tissue whose immune composition is actively remodeled by injury, aging, and disease. How these context-dependent immune states shape vaccine uptake and downstream immune responses remains poorly understood. In this review, we examine the immune landscape of skeletal muscle in health and disease and discuss how its intrinsic regenerative programs, and their disruption in conditions such as sarcopenia, may influence intramuscular vaccine responses.

Indexed as

Muscle, SkeletalVaccinationVaccinesAgingAnimalsHumansInjections, IntramuscularRegenerationSarcopeniaVaccinesagingmuscle biologymuscle regenerationsarcopeniavaccination

Identifiers

PMID42099631
PMCPMC13144008

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.